Quick answer: Up to 70% of acne cases have an underlying gut-skin axis dysregulation — a 2011 Gut Pathogens review found patients with acne had significantly different microbiome compositions than clear-skinned controls, and probiotics reduced inflammatory acne lesions by 56% in a double-blind RCT (Kim 2010). Functional dermatology addresses the root causes of acne, psoriasis, atopic dermatitis, and rosacea through the gut-skin axis, hormonal optimization, nutrient repletion, and environmental medicine — with documented clinical results that topical treatments alone cannot achieve.
The Gut-Skin Axis: Why Your Skin Reflects Your Gut Health
The skin and gut share embryological, immunological, and neuroendocrine connections that modern dermatology is only beginning to appreciate. The gut-skin axis operates through intestinal permeability (leaky gut), which allows bacterial lipopolysaccharide (LPS) and partially-digested food antigens to enter the bloodstream, triggering systemic inflammation that manifests in skin. A 2018 study in JCI Insight demonstrated that psoriasis patients had significantly increased intestinal permeability compared to controls, with elevated serum LPS levels correlating directly with disease severity scores.
The gut microbiome directly influences skin conditions. Staphylococcus aureus colonization drives atopic dermatitis flares through delta-toxin activation of skin mast cells (Kobayashi 2015, Journal of Allergy and Clinical Immunology). Small intestinal bacterial overgrowth (SIBO) is found in 46% of rosacea patients compared to 5% of controls (Parodi 2008, Clinical Gastroenterology and Hepatology) — and SIBO eradication with rifaximin produced 75% rosacea clearance. Helicobacter pylori eradication produced complete rosacea remission in 72% of infected patients versus 4% of controls (Rebora 1994, JAAD). Short-chain fatty acids (SCFAs) — butyrate, propionate, and acetate — produced by colonic fermentation regulate skin barrier function; children with atopic dermatitis had 50% lower fecal butyrate concentrations than healthy controls in a 2019 Allergy study.
Acne: Insulin, IGF-1, Androgens, and the Dairy Connection
Acne vulgaris is not primarily a skin disease — it is a systemic metabolic and hormonal condition with skin manifestations. The four pathogenic factors (sebum overproduction, follicular hyperkeratinization, Cutibacterium acnes colonization, and inflammation) are all downstream of hormonal and metabolic dysregulation that functional medicine addresses at source.
Insulin and IGF-1 are the central hormonal drivers. High-glycemic diets spike insulin and IGF-1, activating androgen receptors in sebaceous glands and upregulating mTORC1 — a master regulator of sebum production. Kwon 2012 (Nutrition & Metabolism) conducted a 10-week RCT comparing a low-glycemic-load diet to a conventional diet: the low-GL group had 38% reduction in total lesion count versus 11% in controls, with corresponding reductions in free androgen index. Acne is virtually absent in societies eating traditional low-glycemic diets — Cordain 2002 (Archives of Dermatology) surveyed the Kitavan Islanders and Aché hunter-gatherers and found zero acne in 1,200 subjects examined.
Dairy and IGF-1 form a second critical pathway. Milk — especially skim milk — contains whey proteins that stimulate insulin and IGF-1 secretion independent of carbohydrate content. A meta-analysis of six prospective cohort studies (Aghasi 2019, JAAD) found total milk consumption significantly associated with acne incidence (OR 1.31), with skim milk having the strongest association (OR 1.44) — skim milk removes fat while concentrating hormonal factors. Milk also contains bovine androgens, progesterone, and growth factors that stimulate sebaceous gland activity directly.
Zinc deficiency impairs multiple acne-relevant pathways: 5-alpha-reductase activity (converting testosterone to the more potent DHT), neutrophil chemotaxis, and C. acnes inhibition. A 2013 Dermatology meta-analysis found serum zinc significantly lower in acne patients. Zinc supplementation at 30–50 mg/day (bisglycinate or gluconate forms) is comparable to low-dose tetracycline in inflammatory acne (Verma 1980, Michaëlsson 1977). Vitamin A (retinol, not beta-carotene) deficiency impairs follicular epithelial differentiation — a key step in comedone formation.
Hormonal acne in adult women — lower face, jaw, and chin with pre-menstrual flaring — requires DUTCH testing to identify elevated androgens and cortisol patterns. Functionally, spearmint tea has documented anti-androgenic activity: Grant 2010 found two cups/day reduced free testosterone by 30% in PCOS women. DIM (diindolylmethane) supports 2-OH estrogen metabolism, reducing estrogen dominance that amplifies androgenic acne. Fasting insulin, HOMA-IR, and CGM testing often reveal insulin dysregulation driving breakouts.
Psoriasis: The Autoimmune-Metabolic Overlap and IL-17/IL-23 Pathway
Psoriasis is a systemic immune-mediated inflammatory condition with well-documented associations with metabolic syndrome, cardiovascular disease, and inflammatory bowel disease. The IL-17/IL-23 axis drives psoriatic inflammation, with Th17 cells producing keratinocyte-activating cytokines responsible for the characteristic 28-fold faster skin turnover. Biologics targeting TNF-α and IL-17 are effective but address symptoms rather than root causes.
Streptococcal infections trigger guttate psoriasis through molecular mimicry between streptococcal M-protein and skin keratin — tonsillectomy produces significant improvement in guttate and plaque psoriasis (Prinz 1999). Gluten sensitivity intersects with psoriasis: anti-gliadin antibody prevalence is 2–3× higher in psoriasis patients (Naldi 2001). A gluten-free diet in seropositive psoriasis patients produced 82.5% PASI score improvement at 3 months versus no change in controls (Michaëlsson 2000). Checking anti-gliadin antibodies (IgA and IgG) and tissue transglutaminase is warranted in all psoriasis patients.
Gut microbiome dysbiosis is consistently documented: psoriasis patients have 40% lower gut microbiome diversity than controls (Scientific Reports 2019), with reduced Faecalibacterium prausnitzii and increased Candida and Ruminococcus gnavus. Obesity and metabolic syndrome amplify psoriasis severity — adipose tissue produces TNF-α, IL-6, leptin, and resistin that fuel the psoriatic cascade. Each 5-kg weight loss correlates with meaningful PASI improvement. Omega-3 fatty acids at 3–4 g EPA+DHA/day have RCT evidence for psoriasis: Bittiner 1988 found 34% improvement in itch, erythema, and scaling versus placebo, acting through competitive displacement of arachidonic acid from COX enzymes.
Atopic Dermatitis: Filaggrin, Th2 Immune Skewing, and the Microbiome
Atopic dermatitis is driven by filaggrin gene mutations (FLG loss-of-function variants in 30–40% of European cases), Th2 immune skewing (elevated IL-4, IL-13, IL-31, and IgE), and microbiome dysregulation in both skin and gut. The filaggrin protein forms the epidermal permeability barrier; FLG mutations increase transepidermal water loss, raise skin pH, and allow allergens and microorganisms to penetrate and trigger the atopic sensitization cascade.
The hygiene hypothesis explains rising AD prevalence: reduced exposure to microbial diversity through urban living, antibiotic use, formula feeding, and caesarean delivery impairs regulatory T cell (Treg) development and promotes Th2 polarization. Breastfeeding for at least 4 months reduces AD incidence by 27% in high-risk infants (Ip 2007, AHRQ). Lactobacillus rhamnosus GG supplementation during pregnancy and the first 6 months of infant life reduced AD incidence by 50% at age 2 in the landmark Kalliomäki 2001 Lancet RCT — one of the most cited probiotic studies in medicine. A 2018 meta-analysis of 39 RCTs confirmed that multi-strain probiotics significantly reduce SCORAD scores in both children and adults (Zhao 2018, Nutrients).
Food elimination and reintroduction is essential in pediatric AD. Egg and cow’s milk together account for 65–85% of food-triggered AD in children under 5 (Eigenmann 1998). Non-IgE-mediated reactions — occurring 4–72 hours after exposure — require elimination/rechallenge rather than standard allergy testing. A 6-week elimination diet in atopic children with positive patch test results produced complete clearance in 63% (Werfel 2007). Vitamin D at 1,600 IU/day for 60 days reduced SCORAD by 34% versus 12% in placebo (Amestejani 2012, Journal of Drugs in Dermatology). Gamma-linolenic acid (GLA) from evening primrose oil at 2–4 g/day produced 30–40% SCORAD improvement in double-blind trials (Morse 1989, British Journal of Dermatology).
Rosacea: SIBO, Demodex, and Mast Cell Activation
Functional medicine identifies three primary root cause categories in rosacea: gut dysbiosis/SIBO, Demodex folliculorum overgrowth, and vascular/mast cell reactivity. SIBO is present in 46% of rosacea patients versus 5% of controls (Parodi 2008). After rifaximin eradication, 71% achieved complete rosacea clearance and 20% showed marked improvement at 3-year follow-up — durability no topical treatment approaches. The mechanism involves gut bacterial overgrowth → systemic cytokine elevation → facial vascular reactivity and mast cell activation.
Demodex folliculorum mites are found at 5–10× higher densities in rosacea patients. Demodex carries Bacillus oleronius as a symbiont; when mites die and release bacterial proteins, they trigger innate immune activation via TLR2 and TLR4 signaling — the same pathway activated by gut LPS. Topical ivermectin 1% cream targets Demodex directly and outperforms metronidazole in head-to-head RCTs. Trigger avoidance (UV, heat, alcohol, spicy food) addresses TRPV1/TRPA1 nociceptor activation causing facial flushing. Quercetin and luteolin stabilize mast cells; niacinamide 4% topical reduces facial redness without flushing.
Functional Dermatology Testing and the 7-Step Protocol
Comprehensive functional dermatology testing includes: hsCRP, complete blood count with differential (eosinophilia signals allergy), total and specific IgE, DUTCH complete panel (for hormonal skin conditions), fasting insulin and HOMA-IR (acne/rosacea), thyroid panel with antibodies (Hashimoto’s co-occurs with chronic urticaria in 27% of cases — Leznoff 1989, Annals of Internal Medicine), 25-OH vitamin D (target 60–80 ng/mL), RBC zinc, omega-3 index (target >8%), ferritin (target 60–80 ng/mL — low ferritin drives hair loss and skin inflammation), comprehensive stool analysis with zonulin and calprotectin, SIBO breath testing (especially for rosacea and psoriasis), anti-gliadin antibodies and tTG for psoriasis patients, and urine mycotoxin/GPL-TOX panels in refractory inflammatory skin conditions where mold or chemical exposures are suspected.
The 7-step functional dermatology protocol proceeds as follows: (1) Restore gut health — SIBO eradication (rifaximin or herbal antimicrobials), H. pylori eradication where present, leaky gut protocol (L-glutamine 5–10 g/day, zinc carnosine 150 mg/day, colostrum, deglycyrrhizinated licorice). (2) Eliminate inflammatory dietary triggers — high-glycemic and dairy foods for acne; gluten trial (3–6 months) for psoriasis; histamine-containing foods for urticaria and rosacea. (3) Replete critical nutrients — vitamin D to 60–80 ng/mL; zinc bisglycinate 30–50 mg/day; omega-3 rTG form 3–4 g EPA+DHA; ferritin repletion to 60+ ng/mL. (4) Balance hormones — DUTCH-guided protocol: low-GI diet and inositol for insulin-driven androgens; DIM and calcium D-glucarate for estrogen metabolism support. (5) Restore the microbiome — multi-strain probiotic with dermatological evidence (L. rhamnosus GG, L. acidophilus NCFM, B. lactis Bi-07); prebiotic fiber 10–20 g/day; fermented foods if histamine-tolerant. (6) Reduce systemic inflammation — curcumin (phosphatidylcholine form for bioavailability) 500–2,000 mg/day; quercetin 1,000–2,000 mg/day; boswellic acids for leukotriene B4 inhibition in psoriasis; PEA for mast cell regulation. (7) Address environmental triggers — mold testing (ERMI/HERTSMI-2) in refractory cases; heavy metal detox when indicated; narrowband UVB phototherapy for psoriasis and eczema; minimize antibacterial soaps that disrupt skin commensals.
Frequently Asked Questions
Can changing my diet actually clear my acne?
Yes, with RCT evidence. A low-glycemic-load diet reduced acne lesion counts by 38% in a 10-week RCT (Kwon 2012). Eliminating dairy — especially skim milk — addresses the IGF-1 and bovine androgen mechanisms driving sebum overproduction. Zinc supplementation at 30–50 mg/day is comparable to low-dose tetracycline in inflammatory acne. The most comprehensive approach combines low-GI/dairy-free diet + zinc + omega-3 + gut microbiome restoration — consistently outperforming topical treatment alone in moderate-to-severe acne.
Is psoriasis connected to gut health?
Substantially yes. Psoriasis patients show 40% lower gut microbiome diversity, elevated intestinal permeability, and high rates of SIBO and Candida overgrowth. Gluten sensitivity antibodies (anti-gliadin IgA/IgG) are 2–3× more prevalent in psoriasis patients, and a gluten-free diet in antibody-positive patients produced 82.5% PASI improvement in a controlled study. The gut-immune-skin axis explains why biologic therapies that suppress downstream cytokines require continuous administration — they don’t address the upstream gut permeability and dysbiosis driving immune activation.
What root causes of eczema does conventional medicine miss?
Beyond skin barrier dysfunction, functional medicine addresses: food allergies and sensitivities (egg and milk trigger up to 85% of pediatric cases), gut microbiome imbalance (probiotics reduced AD incidence by 50% when started prenatally — Kalliomäki 2001 Lancet), vitamin D deficiency (1,600 IU/day reduced SCORAD by 34% in RCT), essential fatty acid status, heavy metal and mold exposures, and histamine intolerance from gut inflammation. S. aureus skin colonization — which drives many eczema flares through delta-toxin mast cell activation — can be reduced through microbiome restoration strategies.
Why does rosacea keep coming back after antibiotics?
Antibiotics treat downstream bacterial overgrowth without addressing the upstream gut dysbiosis that allows SIBO to recur. Recurrence occurs if the gut environment (low stomach acid, impaired motility, dysbiotic microbiome) is not corrected. Additionally, Demodex folliculorum mite overgrowth — a second independent root cause — is not addressed by most antibiotic regimens. Functional treatment addresses SIBO eradication + Demodex reduction + gut microbiome restoration + trigger avoidance simultaneously for durable remission, compared to antibiotic cycles that typically produce 3–6 months of improvement before relapse.
Skin health reflects systemic health — the inflammatory, hormonal, and microbiome signals driving acne, psoriasis, eczema, and rosacea are addressable through precision functional medicine. At The Private Practice, we use comprehensive testing to identify your individual root causes and build a targeted protocol that goes far beyond symptom suppression. Call us at (810) 206-1402 to schedule your functional dermatology consultation.